Cited by 1,513Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis Research

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid

Mullan, Mike, Crawford, Fiona, Axelman, Karin, Houlden, Henry, Lilius, Lena, Winblad, Bengt, Lannfelt, Lars·1992·Nature Genetics

DOI 10.1038/ng0892-345

Open this paper in CoChat — free account

Abstract

Mutations at codon 717 in exon 17 of the beta-amyloid precursor protein (APP) gene have previously been shown to segregate with early onset Alzheimer's disease in some families. We have identified a double mutation at codons 670 and 671 (APP 770 transcript) in exon 16 which co-segregates with the disease in two large (probably related) early-onset Alzheimer's disease families from Sweden. Two base pair transversions (G to T, A to C) from the normal sequence predict Lys to Asn and Met to Leu amino acid substitutions at codons 670 and 671 of the APP transcript. This mutation occurs at the amino terminal of beta-amyloid and may be pathogenic because it occurs at or close to the endosomal/lysosomal cleavage site of the molecule. Thus, pathogenic mutations in APP frame the beta-amyloid sequence.

Integrity signals

Registry

Crossref · 10.1038/ng0892-345

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Self-citation
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
The molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
Cleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor
Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,403
Mutation of the Alzheimer's Disease Amyloid Gene in Hereditary Cerebral Hemorrhage, Dutch Type
Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I. M., van Duinen, S. G., Bots, G. T. A. M., Luyendijk, W., & Frangione, B. (1990) · Science · doi:10.1126/science.2111584 · Cited by 1,399
Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene
Chartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., et al. (1991) · Nature · doi:10.1038/353844a0 · Cited by 1,214
Self-citation
A mutation in the Amyloid Precursor Protein Associated with Hereditary Alzheimer's Disease
Murrell, J. R., Farlow, M. R., Ghetti, B. F., & Benson, M. D. (1991) · Science · doi:10.1126/science.1925564 · Cited by 1,142

Show all 22 references

Research works printed but not linked: 2

Hardy, J. et al. Lancet 337, 1342–1343 (1991).
Weeks, D.E., Ott, J. & Lathrop, G M. Am. J. hum. Genet. 47(3), A204 (1990).

Sorted by citations

Items 801–900 of 1,002

Biological Markers for the Clinical Diagnosis of Alzheimer's Disease.
Arai, H. (1996) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.179.65 · Cited by 21
Alzheimer's α‐secretase may be a calcium‐dependent protease
Chen, M. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01214-3 · Cited by 21
No founder effect in three novel Alzheimer's disease families with APP 717 Val-->Ile mutation. Clerget-darpoux. French Alzheimer's Disease Study Group.
Campion, D., Brice, A., Hannequin, D., Charbonnier, F., Dubois, B., Martin, C., Michon, A., Penet, C., Bellis, M., Calenda, A., et al. (1996) · Journal of Medical Genetics · doi:10.1136/jmg.33.8.661 · Cited by 22
Chlorpromazine reduces toxicity and Ca2+ uptake induced by amyloid β protein (25–35) in vitro
Ueda, K., Yagami, T., Asakura, K., & Kawasaki, K. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01300-5 · Cited by 21
No linkage to chromosome 14 in Swedish Alzheimer's disease families
Lannfelt, L., Lilius, L., Appelgren, H., Axelman, K., Forsell, C., Liu, L., Johansson, K., & Graff, C. (1993) · Nature Genetics · doi:10.1038/ng0793-218 · Cited by 21
Self-citation
Differential effects of familial Alzheimer’s disease-causing mutations on amyloid precursor protein (APP) trafficking, proteolytic conversion, and synaptogenic activity
Schilling, S., Pradhan, A., Heesch, A., Helbig, A., Blennow, K., Koch, C., Bertgen, L., Koo, E. H., Brinkmalm, G., Zetterberg, H., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01577-y · Cited by 21
Using Drosophila amyloid toxicity models to study Alzheimer's disease
Tsintzas, E., & Niccoli, T. (2024) · Annals of Human Genetics · doi:10.1111/ahg.12554 · Cited by 20
The Swedish dilemma - the almost exclusive use of APPswe-based mouse models impedes adequate evaluation of alternative β-secretases
Armbrust, F., Bickenbach, K., Marengo, L., Pietrzik, C. U., & Becker‐Pauly, C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119164 · Cited by 21
Genomic analysis of response to traumatic brain injury in a mouse model of Alzheimer's disease (APPsw)
Crawford, F., Wood, M., Ferguson, S., Mathura, V. S., Faza, B., Wilson, S., Fan, T., O'Steen, B. E., Ait‐Ghezala, G., Hayes, R. L., et al. (2007) · Brain Research · doi:10.1016/j.brainres.2007.09.042 · Cited by 20
Self-citation
The molecular significance of amyloid β-peptide for Alzheimer's disease
Haass, C. (1996) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02189111 · Cited by 20
Glutamate, beta-amyloid precursor proteins, and calcium mediated neurofibrillary degeneration
Smith‐Swintosky, V. L., & Mattson, M. P. (1994) · Springer eBooks · doi:10.1007/978-3-7091-9350-1_3 · Cited by 20
Metabolism of Amyloid Proteins
Benson, M. D., Kluve‐Beckerman, B., Liepnieks, J. J., Murrell, J. R., Hanes, D. A., & Uemichi, T. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514924.ch7 · Cited by 20
Alzheimer’s Disease
Hardy, J. (1994) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30343-4 · Cited by 20
Systemic LPS-induced Aβ-solubilization and clearance in AβPP-transgenic mice is diminished by heparanase overexpression
Jendresen, C., Digre, A., Cui, H., Zhang, X., Vlodavsky, I., Li, J.-P., & Nilsson, L. N. G. (2019) · Scientific Reports · doi:10.1038/s41598-019-40999-4 · Cited by 19
Alzheimer’s disease basics: we all should know
Das, S. K. (2025) · Neurological Research · doi:10.1080/01616412.2025.2529560 · Cited by 19
Novel APP K724M mutation causes Chinese early-onset familial Alzheimer's disease and increases amyloid-β42 to amyloid-β40 ratio
Peng, X.-L., Hou, L., Xu, S., Hua, Y., Zhou, S.-J., Zhang, Y., Zheng, Y.-P., Fu, Y.-H., Xu, Q., Zhang, L.-S., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.06.005 · Cited by 19
Predicting Cognitive Decline across Four Decades in Mutation Carriers and Non-carriers in Autosomal-Dominant Alzheimer’s Disease
Almkvist, O., Rodriguez‐Vieitez, E., Þórðardóttir, S., Amberla, K., Axelman, K., Basun, H., Ståhlbom, A. K., Lilius, L., Remes, A. M., Wahlund, L., et al. (2017) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617716001028 · Cited by 19
Self-citation
Experimental Pharmacology in Transgenic Rodent Models of Alzheimer’s Disease
Cuello, A. C., Hall, H., & Carmo, S. D. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00189 · Cited by 21
Human–Soybean Allergies: Elucidation of the Seed Proteome and Comprehensive Protein–Protein Interaction Prediction
Dick, K., Pattang, A., Hooker, J. C., Nissan, N., Sadowski, M., Barnes, B., Tan, L. H., Burnside, D. J., Phanse, S., Aoki, H., et al. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00138 · Cited by 20
Early and progressive deficit of neuronal activity patterns in a model of local amyloid pathology in mouse prefrontal cortex
Koukouli, F., Rooy, M., & Maskos, U. (2016) · Aging · doi:10.18632/aging.101136 · Cited by 21
Genomics: New Light on Alzheimer’s Disease Research
Jung, Y. J., Kim, Y. H., Bhalla, M., Lee, S. B., & Seo, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123771 · Cited by 19
Disordered proteins in dementia
Ingelsson, M., & Hyman, B. T. (2002) · Annals of Medicine · doi:10.1080/078538902320322529 · Cited by 20
Erbliche Ursachen und Risikofaktoren der Alzheimer-Krankheit
Lautenschlager, N. T., Kurz, A., & Müller, U. (1999) · Der Nervenarzt · doi:10.1007/s001150050423 · Cited by 19
Clinical and neurobiological correlates of D10S1423 genotype in Alzheimer’s disease
Zubenko, G. S., Hughes, H. B., & Stiffler, J. S. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00021-9 · Cited by 19
APP Gene Promoter Constructs Are Preferentially Expressed in the CNS and Testis of Transgenic Mice
Fox, N. W., Johnstone, E. M., Ward, K. E., Schrementi, J. P., & Little, S. P. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7728 · Cited by 19
An Overview of Alzheimer’s Disease Research
Khachaturian, Z. S. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00026-6 · Cited by 19
MOLECULAR GENETICS OF ALZHEIMER'S DISEASE With special emphasis on presenilin, amyloid beta precursor protein and apolipoprotein E genes
Yliopisto, K., & Helisalmi, S. (1998) · Cited by 19
NADH Fluorescence Lifetime Imaging Microscopy Reveals Selective Mitochondrial Dysfunction in Neurons Overexpressing Alzheimer’s Disease–Related Proteins
Niederschweiberer, M. A., Schaefer, P. M., Singh, L. N., Lausser, L. M., Bhosale, D., Hesse, R., Calzia, E., Kestler, H. A., Rueck, A. C., Wallace, D. C., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.671274 · Cited by 18
Refining the amyloid β peptide and oligomer fingerprint ambiguities in Alzheimer’s disease: Mass spectrometric molecular characterization in brain, cerebrospinal fluid, blood, and plasma
Michno, W., Blennow, K., Zetterberg, H., & Brinkmalm, G. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15466 · Cited by 18
Diets with Higher ω-6/ω-3 Ratios Show Differences in Ceramides and Fatty Acid Levels Accompanied by Increased Amyloid-Beta in the Brains of Male APP/PS1 Transgenic Mice
Ordóñez‐Gutiérrez, L., Fabriàs, G., Casas, J., & Wandosell, F. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010907 · Cited by 19
Sodium–calcium exchanger isoform-3 targeted Withania somnifera (L.) Dunal therapeutic intervention ameliorates cognition in the 5xFAD mouse model of Alzheimer’s disease
Afewerky, H. K., Li, H., Zhang, T., Li, X., Mahaman, Y. A. R., Duan, L., Qin, P., Zheng, J., Pei, L., & Lu, Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-05568-2 · Cited by 18
SUMO modulation of protein aggregation and degradation
Feligioni, M., Marcelli, S., Knock, E., Nadeem, U., Arancio, O., & Fraser, P. E. (2015) · AIMS molecular science · doi:10.3934/molsci.2015.4.382 · Cited by 19
FAD Mutations in Amyloid Precursor Protein Do Not Directly Perturb Intracellular Calcium Homeostasis
Stieren, E. S., Werchan, W. P., Ayadi, A. E., Li, F., & Boehning, D. F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011992 · Cited by 18
Inference of Causative Genes for Alzheimer’s Disease Due to Dosage Imbalance
Sekine, M., & Makino, T. (2017) · Molecular Biology and Evolution · doi:10.1093/molbev/msx183 · Cited by 18
Alzheimer Aβ Assemblies Accumulate in Excitatory Neurons upon Proteasome Inhibition and Kill Nearby NAKα3 Neurons by Secretion
Komura, H., Kakio, S., Sasahara, T., Arai, Y., Takino, N., Sato, M., Satomura, K., Ohnishi, T., Nabeshima, Y.-I., Muramatsu, S., et al. (2019) · iScience · doi:10.1016/j.isci.2019.01.018 · Cited by 18
Amyloidogenic processing of amyloid β protein precursor (APP) is enhanced in the brains of alcadein α–deficient mice
Gotoh, N., Saito, Y., Hata, S., Saito, H., Ojima, D., Murayama, C., Shigeta, M., Abe, T., Konno, D., Matsuzaki, F., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012386 · Cited by 18
Cerebrospinal Fluid YKL-40 and Neurogranin in Familial Alzheimer’s Disease: A Pilot Study
Þórðardóttir, S., Almkvist, O., Johansson, C., Zetterberg, H., Blennow, K., & Graff, C. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191261 · Cited by 18
Chronic effects of blast injury on the microvasculature in a transgenic mouse model of Alzheimer’s disease related Aβ amyloidosis
Clark, A. T., Abrahamson, E. E., Harper, M. M., & Ikonomović, M. D. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-021-00301-z · Cited by 18
Experimental approaches for altering the expression of Abeta‐degrading enzymes
Loeffler, D. A. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15762 · Cited by 18
Brainwide distribution and variance of amyloid-beta deposits in tg-ArcSwe mice
Lillehaug, S., Skaaraas, G. H. E. S., Nilsson, L. N. G., Bjaalie, J. G., Leergaard, T. B., & Torp, R. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.013 · Cited by 18
Concept of Disease in Geriatric Psychiatry
Krishnan, K. (2006) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000224600.37387.4b · Cited by 18
Effects of sulindac sulfide on the membrane architecture and the activity of γ-secretase
Gamerdinger, M., Clement, A. B., & Behl, C. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.02.009 · Cited by 18
Amyloid precursor protein mutation at codon 713 (Ala → Val) does not cause schizophrenia: non-pathogenic variant found at codon 705 (silent)
Forsell, C., & Lannfelt, L. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(94)11176-j · Cited by 19
Self-citation
Immunological approaches as therapy for Alzheimer’s disease
Solomon, B. (2002) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2.8.907 · Cited by 18
Early onset Alzheimer's disease in a South American pedigree from Argentina
Mangone, C. A., Castaño, E. M., Levy, E., Abiusi, G., Wisniewski, T., Marques, M. R., Faccio, E., Gorelick, P. B., Frangione, B., & Sica, R. E. P. (1995) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1995.tb05835.x · Cited by 10
Initial results of a genome survey for novel alzheimer's disease risk genes: Association with a locus on the X chromosome
Zubenko, G. S., Stiffler, J. S., Hughes, H. B., Hurtt, M. R., & Kaplan, B. B. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980328)81:2 · Cited by 18
E674Q (Shanghai APP mutant), a novel amyloid precursor protein mutation, in familial late-onset Alzheimer's disease
Zhang, Y., Xie, X., Chen, B., Pan, L., Li, J., Wang, W., Wang, J., Tang, R., Huang, Q., Chen, X., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.02.051 · Cited by 19
Application of CRISPR/Cas9 System in the Treatment of Alzheimer’s Disease and Neurodegenerative Diseases
Rahimi, A., Sameei, P., Mousavi, S., Ghaderi, K., Hassani, A., Hassani, S., & Alipour, S. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04143-2 · Cited by 18
Lessons on Differential Neuronal-Death-Vulnerability from Familial Cases of Parkinson’s and Alzheimer’s Diseases
Franco, R., Navarro, G., & Martínez‐Pinilla, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133297 · Cited by 17
Anti-Amyloidogenic Effects of Asarone Derivatives From Perilla frutescens Leaves Against Beta-Amyloid Aggregation and Nitric Oxide Production
Lee, J. E., Kim, N., Yeo, J. Y., Seo, D.-G., Kim, S., Lee, J.-S., Hwang, K. W., & Park, S. (2019) · Molecules · doi:10.3390/molecules24234297 · Cited by 17
New BACE1 Chimeric Peptide Inhibitors Selectively Prevent AβPP-β Cleavage Decreasing Amyloid-β Production and Accumulation in Alzheimer’s Disease Models
Resende, R., Ferreira‐Marques, M., Moreira, P., Coimbra, J. R. M., Baptista, S. J., Isidoro, C., Salvador, J. A. R., Dinis, T. C. P., Pereira, C., & Santos, A. E. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200381 · Cited by 17
Entering a new era of quantifying glutamate clearance in health and disease
Brymer, K. J., Barnes, J. R., & Parsons, M. P. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24810 · Cited by 17
Tmem27 dimerization, deglycosylation, plasma membrane depletion, and the extracellular Phe-Phe motif are negative regulators of cleavage by Bace2
Esterházy, D., Akpınar, P., & Stoffel, M. (2012) · Biological Chemistry · doi:10.1515/hsz-2012-0104 · Cited by 17
Aβ Infusion and Related Models of Alzheimer Dementia
Lawlor, P. A., & Young, D. (2010) · Neuromethods · doi:10.1007/978-1-60761-898-0_17 · Cited by 19
Clinical Bioavailability of the Novel BACE1 Inhibitor Lanabecestat (AZD3293): Assessment of Tablet Formulations Versus an Oral Solution and the Impact of Gastric pH on Pharmacokinetics
Ye, N., Monk, S. A., Daga, P., Bender, D. M., Rosen, L. B., Mullen, J., Minkwitz, M. C., & Kugler, A. R. (2018) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.422 · Cited by 17
Assessment of allele-specific gene silencing by RNA interference with mutant and wild-type reporter alleles.
Ohnishi, Y., Tokunaga, K., Kaneko, K., & Hohjoh, H. (2006) · Europe PMC (PubMed Central) · Cited by 17
Exons 16 and 17 of the amyloid precursor protein gene in familial inclusion body myopathy
Sivakumar, K., Červen̆áková, L., Dalakas, M. C., Leon‐Monzon, M., Isaacson, S., Nagle, J. W., Vasconcelos, O. M., & Goldfarb, L. G. (1995) · Annals of Neurology · doi:10.1002/ana.410380222 · Cited by 17
The Kunitz-protease inhibitor domain in amyloid precursor protein reduces cellular mitochondrial enzymes expression and function
Chua, L. M., Lim, M., & Wong, B. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.07.022 · Cited by 17
Binding of the Alzheimer amyloid β-peptide to neuronal cell membranes by fluorescence correlation spectroscopy
Hossain, S., Grande, M., Ahmadkhanov, G., & Pramanik, A. (2007) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2007.01.008 · Cited by 17
Transgenic models for Alzheimer's disease
Duff, K. (1998) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1998.00006.x · Cited by 17
Low frequency of the APP670/671 mutation in familial Alzheimer's disease in Sweden
Lannfelt, L., Viitanen, M. H., Johansson, K., Axelman, K., Lilius, L., Almqvist, E. W., & Winblad, B. G. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90083-w · Cited by 17
Self-citation
Cerebral Amyloid Angiopathy in a Mouse Model of Alzheimer’s Disease Associates with Upregulated Angiopoietin and Downregulated Hypoxia-Inducible Factor
Skaaraas, G. H. E. S., Melbye, C., Puchades, M. A., Leung, D. S. Y., Jacobsen, Ø., Rao, S. B., Ottersen, O. P., Leergaard, T. B., & Torp, R. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210571 · Cited by 16
Loss of TREM2 diminishes CAA despite an overall increase of amyloid load in Tg‐SwDI mice
Zhong, R., Xu, Y., Williams, J. W., & Li, L. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14222 · Cited by 16
Animal Research for Alzheimer Disease: Failures of Science and Ethics
Pippin, J. J., Cavanaugh, S. E., & Pistollato, F. (2019) · BRILL eBooks · doi:10.1163/9789004391192_021 · Cited by 16
Molecular Genetics of Familial Alzheimer Disease
Shastry, B. S. (1998) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40324-6 · Cited by 16
Early loss of locus coeruleus innervation promotes cognitive and neuropathological changes before amyloid plaque deposition in a transgenic rat model of Alzheimer's disease
Aguilar, L. F., Hall, H., Orciani, C., Foret, M. K., Kovecses, O., Ducatenzeiler, A., & Cuello, A. C. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12835 · Cited by 17
Effects of NK-4 in a Transgenic Mouse Model of Alzheimer's Disease
Ohta, H., Arai, S., Akita, K., Ohta, T., & Fukuda, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030007 · Cited by 17
Effect of amyloid β on capacitive calcium entry in neural 2a cells
Niu, Y., Su, Z., Zhao, C., Song, B., Zhang, X., Zhao, N., Shen, X., & Gong, Y. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.10.003 · Cited by 16
Recognition Memory and β-amyloid Plaques in Adult Tg2576 Mice are not Modified After Oral Exposure to Aluminum
Ribes, D., Torrente, M., Vicens, P., Colomina, M. T., Gómez, M., & Domingo, J. L. (2011) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3182211ab1 · Cited by 17
Molecular genetics of Alzheimer’s disease
Sorbi, S. (1993) · Aging Clinical and Experimental Research · doi:10.1007/bf03324196 · Cited by 16
Therapeutic Potential of Small Interfering RNA for Central Nervous System Diseases
Lovett‐Racke, A. E., Cravens, P. D., Gocke, A. R., Racke, M. K., & Stüve, O. (2005) · Archives of Neurology · doi:10.1001/archneur.62.12.1810 · Cited by 16
Molecular pathology of Alzheimer's disease
MULLAN, M. J. (1993) · International Review of Psychiatry · doi:10.3109/09540269309037798 · Cited by 16
Self-citation
Application of PET in dementia disorders
Nordberg, A. K. (1996) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1996.tb00377.x · Cited by 16
Theiler's virus as a vector for foreign gene delivery
Zhang, L., Sato, S., Kim, J. I., & Roos, R. P. (1995) · Journal of Virology · doi:10.1128/jvi.69.5.3171-3175.1995 · Cited by 16
Amyloid Precursor Protein Processing in Sterol Regulatory Element-binding Protein Site 2 Protease-deficient Chinese Hamster Ovary Cells
Ross, S. L., Martin, F. H., Simonet, L., Jacobsen, F. W., Deshpande, R. R., Vassar, R. J., Bennett, B., Luo, Y., Wooden, S. K., Hu, S., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15309 · Cited by 16
Brain Amyloid- ß Accumulation in AD Mouse Models Modified by Their Altered Gene Expression in the Presence of Human apoE Isoforms Through Aging ProcessPreprint
Honda, K., Saito, Y., Saito, H., Toyoda, M., Abe, R., Saito, T., Saido, T. C., Michikawa, M., Taru, H., Sobu, Y., et al. (2022) · SSRN Electronic Journal · doi:10.1016/j.neurobiolaging.2022.12.003 · Cited by 16
Modeling Alzheimer’s Disease: A Review of Gene-Modified and Induced Animal Models, Complex Cell Culture Models, and Computational Modeling
Timofeeva, A. M., Aulova, K. S., & Nevinsky, G. A. (2025) · Brain Sciences · doi:10.3390/brainsci15050486 · Cited by 17
RETRACTED: Santacruzamate A Ameliorates AD-Like Pathology by Enhancing ER Stress Tolerance Through Regulating the Functions of KDELR and Mia40-ALR in vivo and in vitro
Chen, L., Liu, Y.-C., Tan, H., Zhang, Y., Xu, J., Liu, W.-L., Li, Z., & Li, W. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00061 · Cited by 15
Retracted
Pulsed Hydrogen–Deuterium Exchange Reveals Altered Structures and Mechanisms in the Aggregation of Familial Alzheimer’s Disease Mutants
Illes‐Toth, E., Meisl, G., Rempel, D. L., Knowles, T. P. J., & Gross, M. L. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00072 · Cited by 15
Emerging Electroencephalographic Biomarkers to Improve Preclinical to Clinical Translation in Alzheimer’s Disease
Cope, Z. A., Murai, T., & Rizzo, S. J. S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.805063 · Cited by 18
The role and therapeutic implication of protein tyrosine phosphatases in Alzheimer’s disease
Zhao, X., Li, X., She, L., Li, L., Huang, P. C., & Liang, G. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113188 · Cited by 15
APP in the Neuromuscular Junction for the Development of Sarcopenia and Alzheimer’s Disease
Wu, M., Zou, W.-J., Lee, D., Mei, L., & Xiong, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097809 · Cited by 17
Neuroinflammation and related neuropathologies in APPSL mice: further value of this in vivomodel of Alzheimer’s disease
Löffler, T., Flunkert, S., Havas, D., Schweinzer, C., Uger, M. D., Windisch, M., Steyrer, E., & Hutter‐Paier, B. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-84 · Cited by 15
Pharmacological Modulations of the Serotonergic System in a Cell-Model of Familial Alzheimer’s Disease
Tajeddinn, W., Persson, T., Calvo‐Garrido, J., Ahmed, M. S., Maioli, S., Vijayaraghavan, S., Kazokoglu, M. S., Parrado‐Fernández, C., Yoshitake, T., Kehr, J., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160046 · Cited by 15
Self-citation
Characterization of the unique In Vitro effects of unsaturated fatty acids on the formation of amyloid β fibrils
Eto, M., Hashimoto, T., Shimizu, T., & Iwatsubo, T. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219465 · Cited by 15
The APP and PS1/2 Mutations Linked to Early Onset Familial Alzheimer’s Disease Increase the Extracellular Concentration of Aβ1–42(43)
Younkin, S. G. (1998) · Springer eBooks · doi:10.1007/978-3-642-72103-8_4 · Cited by 16
Endoplasmic Reticulum Stress Induces Myostatin High Molecular Weight Aggregates and Impairs Mature Myostatin Secretion
Sachdev, R., Kappes‐Horn, K., Paulsen, L., Duernberger, Y., Pleschka, C., Denner, P., Kundu, B., Reimann, J., & Vorberg, I. M. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0997-9 · Cited by 16
Molecular Genetics of Alzheimer’s Disease
George‐Hyslop, P. S. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-726-0_98 · Cited by 15
Mutational analysis of the amyloid precursor protein gene in Japanese familial Alzheimer's disease kindreds
Fujigasaki, H., Naruse, S., Kaneko, K., Hirasawa, H., Tsuji, S., & Miyatake, T. (1994) · Human Genetics · doi:10.1007/bf00201676 · Cited by 15
Human Nervous System
Katzman, R. (1995) · Comprehensive physiology · doi:10.1002/cphy.cp110112 · Cited by 15
Genetic Complexity of Early-Onset Alzheimer’s Disease
Ghani, M., Reitz, C., George‐Hyslop, P. S., & Rogaeva, E. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-72938-1_3 · Cited by 15
Directly Reprogrammed Neurons Express MAPT and APP Splice Variants Pertinent to Ageing and Neurodegeneration
Habekost, M., Qvist, P., Denham, M., Holm, I. E., & Jørgensen, A. L. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02258-w · Cited by 14
EDEM1 Regulates Amyloid Precursor Protein (APP) Metabolism and Amyloid-β Production
Nowakowska-Gołacka, J., Czapiewska, J., Sominka, H., Sowa-Rogozińska, N., & Słomińska-Wojewódzka, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010117 · Cited by 14
Increased Expression of KIF11/Kinesin5 Offsets Alzheimer Aβ-Mediated Toxicity and Cognitive Dysfunction in Cell Culture, Mice, and Humans
Lucero, E., Freund, R. K., Smith, A. N., Johnson, N. R., Dooling, B. R., Sullivan, E. J., Prikhodko, O., Ahmed, M. M., Bennett, D. A., Hohman, T. J., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105288 · Cited by 14
Critical thinking of Alzheimer’s transgenic mouse model: current research and future perspective
Li, X., Quan, M., Wei, Y., Wang, W., Xu, L., Wang, Q., & Jia, J. (2023) · Science China Life Sciences · doi:10.1007/s11427-022-2357-x · Cited by 14
Amplified voltammetric characterization of cleavage of the biotinylated peptide by BACE1 and screening of BACE1 inhibitors
Yi, X., Han, H., Zhang, Y., Wang, J., Zhang, Y., & Zhou, F. (2013) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2013.06.047 · Cited by 14
Retinal changes in the Tg-SwDI mouse model of Alzheimer’s disease
Oliveira-Souza, F. G., DeRamus, M. L., van Groen, T., Lambert, A. E., Bolding, M., & Strang, C. E. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.04.021 · Cited by 14
Novel amyloid precursor protein mutation, Val669Leu (“Seoul APP”), in a Korean patient with early-onset Alzheimer's disease
Bagyinszky, E., Kang, M. J., Giau, V. V., Shim, K., Pyun, J., Suh, J., An, S. S. A., & Kim, S. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.08.026 · Cited by 14
Cholinergic Deep Brain Stimulation for Memory and Cognitive Disorders
Subramaniam, S., Blake, D. T., & Constantinidis, C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210425 · Cited by 15
A novel RNAi library based on partially randomized consensus sequences of nuclear receptors: Identifying the receptors involved in amyloid β degradation
Yang, J., Fan, W., Rogers, C., Chatterton, J. E., Bliesath, J. R., Liu, G., Ning, K., Wang, C., Rhoades, K. L., Wong‐Staal, F., et al. (2006) · Genomics · doi:10.1016/j.ygeno.2006.03.010 · Cited by 14

Authors: Mullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B., & Lannfelt, L.
Affiliations: University of South Florida (US)
Karolinska Institutet (SE)
St Mary's Hospital (GB)
ORCID: Crawford, Fiona
Houlden, Henry
Winblad, Bengt
Lannfelt, Lars
Venue: Nature Genetics
Publisher: Springer Science and Business Media LLC
Published: 1992-08
Volume: 1
Issue: 5
Pages: 345-347
ISSN: 1061-4036 (ISSN-L)
1546-1718
DOI: 10.1038/ng0892-345
OpenAlex: W2030641075
Cited by: 1,513
References: 22
Citations by year: 2026: 24 · 2025: 30 · 2024: 50 · 2023: 47 · 2022: 49 · 2021: 46 · 2020: 52 · 2019: 56 · 2018: 48 · 2017: 48 · 2016: 47 · 2015: 31 · 2014: 62 · 2013: 31 · 2012: 32
FWCI: 49.77
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Genetics (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords: Alzheimer's disease, APP gene, amyloid-beta, early-onset familial Alzheimer's disease, Swedish families
MeSH terms: Alzheimer Disease, Amino Acid Sequence, Base Sequence, Brain, Codon, Exons, Female, Humans, Genetic Linkage, Male, Middle Aged, Molecular Sequence Data, Oligodeoxyribonucleotides, Pedigree, Transcription, Genetic, Genetic Variation, Amyloid beta-Protein Precursor, Point Mutation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks